Does Bortezomib-Dexamethasone-Rituximab-Cyclophosphamide Play a Role in the Treatment of Waldenström's Macroglobulinemia?
Journal of Clinical Oncology · 2023
DOI: 10.1200/jco.23.00649 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Clinical Oncology, 2023. Verfasst von Shayna Sarosiek und 3 weiteren Autor:innen. Beteiligte Einrichtung: Shayna Sarosiek, MD, and Steven P. Treon, MD, PhD, Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, Departmen…. Hauptthemen laut MEDLINE: Waldenstrom Macroglobulinemia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Shayna Sarosiek, MD, and Steven P. Treon, MD, PhD, Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, Department of Medicine, Harvard Medical School, Boston, MA; Andrew R. Branagan,…
ORCID-Profile: Shayna Sarosiek, Steven P Treon, Andrew R Branagan, Jorge J Castillo
Zitieren
APA
Sarosiek, S., Treon, S. P., Branagan, A. R., & Castillo, J. J. (2023). Does Bortezomib-Dexamethasone-Rituximab-Cyclophosphamide Play a Role in the Treatment of Waldenström's Macroglobulinemia?. Journal of Clinical Oncology. https://doi.org/10.1200/jco.23.00649
Vancouver
Sarosiek S, Treon SP, Branagan AR, Castillo JJ. Does Bortezomib-Dexamethasone-Rituximab-Cyclophosphamide Play a Role in the Treatment of Waldenström's Macroglobulinemia?. Journal of Clinical Oncology. 2023. doi:10.1200/jco.23.00649
BibTeX
@article{Sarosiek2023,
author = {Sarosiek, Shayna and Treon, Steven P and Branagan, Andrew R and Castillo, Jorge J},
title = {Does Bortezomib-Dexamethasone-Rituximab-Cyclophosphamide Play a Role in the Treatment of Waldenström's Macroglobulinemia?},
journal = {Journal of Clinical Oncology},
year = {2023},
doi = {10.1200/jco.23.00649}
}
EUVIMED